{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:29:53Z","timestamp":1787758193070,"version":"build-2784847793"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40272-026-00738-5","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:38:54Z","timestamp":1769769534000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimizing Antifungal Therapy for Pediatric Tinea Capitis: A Narrative Review of Species-Specific Efficacy, Dosing Strategies, and Clinical Implications"],"prefix":"10.1007","volume":"28","author":[{"given":"Chester","family":"Tyson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Haydek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-8215","authenticated-orcid":false,"given":"Dean","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"2","key":"738_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/ddg.14026","volume":"18","author":"P Mayser","year":"2020","unstructured":"Mayser P, Nenoff P, Reinel D, Abeck D, Brasch J, Daeschlein G, et al. S1 guidelines: tinea capitis. J Dtsch Dermatol Ges. 2020;18(2):161\u201379. https:\/\/doi.org\/10.1111\/ddg.14026.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"738_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/1872213X14666200106145624","volume":"14","author":"AKC Leung","year":"2020","unstructured":"Leung AKC, Hon KL, Leong KF, Barankin B, Lam JM. Tinea capitis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):58\u201368. https:\/\/doi.org\/10.2174\/1872213X14666200106145624.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"2","key":"738_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/CMR.8.2.240","volume":"8","author":"I Weitzman","year":"1995","unstructured":"Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev. 1995;8(2):240\u201359. https:\/\/doi.org\/10.1128\/CMR.8.2.240.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"738_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/pde.15708","volume":"41","author":"AK Gupta","year":"2024","unstructured":"Gupta AK, Polla Ravi S, Wang T, Faour S, Bamimore MA, Heath CR, et al. An update on tinea capitis in children. Pediatr Dermatol. 2024;41(6):1030\u20139. https:\/\/doi.org\/10.1111\/pde.15708. (Epub 2024 Aug 7).","journal-title":"Pediatr Dermatol"},{"issue":"1-2","key":"738_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11046-016-0058-8","volume":"182","author":"RJ Hay","year":"2017","unstructured":"Hay RJ. Tinea Capitis: current status. Mycopathologia. 2017;182(1\u20132):87\u201393. https:\/\/doi.org\/10.1007\/s11046-016-0058-8. (Epub 2016 Sep 6).","journal-title":"Mycopathologia"},{"issue":"5","key":"738_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11046-022-00702-0","volume":"188","author":"X Wang","year":"2023","unstructured":"Wang X, Abuliezi R, Hasimu H, Zhang L, Abliz P. Retrospective analysis of tinea capitis in Xinjiang, China. Mycopathologia. 2023;188(5):523\u20139. https:\/\/doi.org\/10.1007\/s11046-022-00702-0. (Epub 2023 Apr 3).","journal-title":"Mycopathologia"},{"issue":"2","key":"738_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280948","volume":"18","author":"MY Birhanu","year":"2023","unstructured":"Birhanu MY, Temesgen H, Ketema DB, Desta M, Getaneh T, Bekele GM, et al. Tinea capitis among schoolchildren in Ethiopia: a systematic review and meta analysis. PLoS ONE. 2023;18(2):e0280948. https:\/\/doi.org\/10.1371\/journal.pone.0280948.","journal-title":"PLoS ONE"},{"issue":"1","key":"738_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/npmj.npmj_172_16","volume":"24","author":"AE Fienemika","year":"2017","unstructured":"Fienemika AE, Okeafor CU. The identification and grading of the psychosocial impact of tinea capitis in primary school children in a semi-urban area of Rivers state, Nigeria. Niger Postgrad Med J. 2017;24(1):20\u20134. https:\/\/doi.org\/10.4103\/npmj.npmj_172_16.","journal-title":"Niger Postgrad Med J"},{"issue":"12","key":"738_CR9","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1111\/jdv.15088","volume":"32","author":"AK Gupta","year":"2018","unstructured":"Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Shear NH, Piguet V, et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol. 2018;32(12):2264\u201374. https:\/\/doi.org\/10.1111\/jdv.15088. (Epub 2018 Jul 12).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"738_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/jdv.20147","volume":"39","author":"M Theiler","year":"2025","unstructured":"Theiler M, Luchsinger I, Rast AC, Schwieger-Briel A, Weibel L, Bosshard PP. Precision diagnostics in paediatric dermatology: advancing management of tinea capitis through dermatophyte PCR. J Eur Acad Dermatol Venereol. 2025;39(2):398\u2013403. https:\/\/doi.org\/10.1111\/jdv.20147. (Epub 2024 May 31).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"738_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/myc.13221","volume":"64","author":"F Bongomin","year":"2021","unstructured":"Bongomin F, Olum R, Nsenga L, Namusobya M, Russell L, de Sousa E, et al. Estimation of the burden of tinea capitis among children in Africa. Mycoses. 2021;64(4):349\u201363. https:\/\/doi.org\/10.1111\/myc.13221. (Epub 2020 Dec 9).","journal-title":"Mycoses"},{"issue":"8","key":"738_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/ijd.14352","volume":"58","author":"KV Grigoryan","year":"2019","unstructured":"Grigoryan KV, Tollefson MM, Olson MA, Newman CC. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States. Int J Dermatol. 2019;58(8):912\u20135. https:\/\/doi.org\/10.1111\/ijd.14352. (Epub 2018 Dec 13).","journal-title":"Int J Dermatol"},{"issue":"2","key":"738_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1439-0507.2007.01424.x","volume":"50","author":"G Ginter-Hanselmayer","year":"2007","unstructured":"Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007;50(2):6\u201313. https:\/\/doi.org\/10.1111\/j.1439-0507.2007.01424.x.","journal-title":"Mycoses"},{"issue":"5","key":"738_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11046-023-00762-w","volume":"188","author":"D Zheng","year":"2023","unstructured":"Zheng D, Liang T, Wu W, Al-Odaini N, Pan K, Huang L, et al. The epidemiology of tinea capitis in Guangxi Province, China. Mycopathologia. 2023;188(5):489\u201396. https:\/\/doi.org\/10.1007\/s11046-023-00762-w. (Epub 2023 Jun 25).","journal-title":"Mycopathologia"},{"issue":"5","key":"738_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11046-022-00649-2","volume":"188","author":"YY Xiao","year":"2023","unstructured":"Xiao YY, Zhou YB, Chao JJ, Ma L. Epidemiology of tinea capitis in children in Beijing and adjacent regions, China: a 15-year retrospective study. Mycopathologia. 2023;188(5):531\u20135. https:\/\/doi.org\/10.1007\/s11046-022-00649-2. (Epub 2022 Aug 18).","journal-title":"Mycopathologia"},{"issue":"5","key":"738_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11046-023-00710-8","volume":"188","author":"XQ Chen","year":"2023","unstructured":"Chen XQ, Yu J. Global demographic characteristics and pathogen spectrum of tinea capitis. Mycopathologia. 2023;188(5):433\u201347. https:\/\/doi.org\/10.1007\/s11046-023-00710-8. (Epub 2023 Apr 3).","journal-title":"Mycopathologia"},{"issue":"12","key":"738_CR17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1080\/14787210.2024.2405936","volume":"22","author":"A Bonifaz","year":"2024","unstructured":"Bonifaz A, Lumb\u00e1n-Ram\u00edrez P, Garc\u00eda-Sotelo RS, de la Vidaurri Cruz H, Toledo-Bahena M, Valencia-Herrera A. Now that griseofulvin is not available, what to do with tinea capitis treatments? Expert Rev Anti-Infect Ther. 2024;22(12):1017\u201322. https:\/\/doi.org\/10.1080\/14787210.2024.2405936. (Epub 2024 Sep 19).","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"1","key":"738_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cppeds.2017.11.001","volume":"48","author":"SJ Alter","year":"2018","unstructured":"Alter SJ, McDonald MB, Schloemer J, Simon R, Trevino J. Common child and adolescent cutaneous infestations and fungal infections. Curr Probl Pediatr Adolesc Health Care. 2018;48(1):3\u201325. https:\/\/doi.org\/10.1016\/j.cppeds.2017.11.001. (Epub 2017 Dec 6).","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"2","key":"738_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/pde.15544","volume":"41","author":"L Guo","year":"2024","unstructured":"Guo L, Tran J, Sun DI, Newton JS, D\u2019Amiano NM, Lai J, et al. Management of tinea capitis in infants and children in the United States: a national survey of pediatric dermatologists. Pediatr Dermatol. 2024;41(2):263\u20135. https:\/\/doi.org\/10.1111\/pde.15544. (Epub 2024 Feb 11).","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"738_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/myc.13197","volume":"64","author":"N Aleohin","year":"2021","unstructured":"Aleohin N, Bar J, Bar-Ilan E, Samuelov L, Sprecher E, Mashiah J. Laboratory monitoring during antifungal treatment of paediatric tinea capitis. Mycoses. 2021;64(2):157\u201361. https:\/\/doi.org\/10.1111\/myc.13197. (Epub 2020 Oct 27).","journal-title":"Mycoses"},{"issue":"1","key":"738_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaad.2008.02.019","volume":"59","author":"BE Elewski","year":"2008","unstructured":"Elewski BE, C\u00e1ceres HW, DeLeon L, El Shimy S, Hunter JA, Korotkiy N, et al. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol. 2008;59(1):41\u201354. https:\/\/doi.org\/10.1016\/j.jaad.2008.02.019. (Epub 2008 Apr 18).","journal-title":"J Am Acad Dermatol"},{"key":"738_CR22","unstructured":"Gris-PEG. Label via DailyMed."},{"issue":"2","key":"738_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2133.2001.04022.x","volume":"144","author":"LC Fuller","year":"2001","unstructured":"Fuller LC, Smith CH, Cerio R, Marsden RA, Midgley G, Beard AL, et al. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol. 2001;144(2):321\u20137. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04022.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"738_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1468-3083.2003.00691.x","volume":"17","author":"AK Gupta","year":"2003","unstructured":"Gupta AK, Adamiak A, Cooper EA. The efficacy and safety of terbinafine in children. J Eur Acad Dermatol Venereol. 2003;17(6):627\u201340. https:\/\/doi.org\/10.1046\/j.1468-3083.2003.00691.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"738_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11046-011-9438-2","volume":"172","author":"S Deng","year":"2011","unstructured":"Deng S, Hu H, Abliz P, Wan Z, Wang A, Cheng W, et al. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China. Mycopathologia. 2011;172(5):365\u201372. https:\/\/doi.org\/10.1007\/s11046-011-9438-2. (Epub 2011 Jun 24).","journal-title":"Mycopathologia"},{"issue":"4","key":"738_CR26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1542\/peds.109.4.602","volume":"109","author":"SF Friedlander","year":"2002","unstructured":"Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P, Stewart D, et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics. 2002;109(4):602\u20137. https:\/\/doi.org\/10.1542\/peds.109.4.602.","journal-title":"Pediatrics"},{"issue":"1 Pt 1","key":"738_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0190-9622(00)90001-x","volume":"42","author":"BE Elewski","year":"2000","unstructured":"Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. 2000;42(1 Pt 1):1\u201320. https:\/\/doi.org\/10.1016\/s0190-9622(00)90001-x.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"738_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1525-1470.2001.01978.x","volume":"18","author":"AK Gupta","year":"2001","unstructured":"Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol. 2001;18(5):433\u20138. https:\/\/doi.org\/10.1046\/j.1525-1470.2001.01978.x.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"738_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15320","volume":"35","author":"YB Zhou","year":"2022","unstructured":"Zhou YB, Chao JJ, Xiao YY, Ma L. High-dose oral terbinafine in the treatment of pediatric tinea capitis under 2\u2009years old. Dermatol Ther. 2022;35(4):e15320. https:\/\/doi.org\/10.1111\/dth.15320. (Epub 2022 Jan 20).","journal-title":"Dermatol Ther"},{"key":"738_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1297339","volume":"11","author":"JK Hwang","year":"2023","unstructured":"Hwang JK, Gold JAW, Paller AS, Lipner SR. Low utilization of confirmatory testing for tinea capitis by pediatricians at an academic center in New York, United States, 2005-2021. Front Pediatr. 2023;11:1297339. https:\/\/doi.org\/10.3389\/fped.2023.1297339.","journal-title":"Front Pediatr"},{"issue":"5","key":"738_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02522-17","volume":"62","author":"SM Rudramurthy","year":"2018","unstructured":"Rudramurthy SM, Shankarnarayan SA, Dogra S, Shaw D, Mushtaq K, Paul RA, et al. Mutation in the squalene epoxidase gene of Trichophyton interdigitale and Trichophyton rubrum associated with allylamine resistance. Antimicrob Agents Chemother. 2018;62(5):e02522-17. https:\/\/doi.org\/10.1128\/AAC.02522-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"738_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2147\/IDR.S246025.PMID:32214830;PMCID:PMC7078656","volume":"13","author":"S Taghipour","year":"2020","unstructured":"Taghipour S, Shamsizadeh F, Pchelin IM, Rezaei-Matehhkolaei A, Zarei Mahmoudabadi A, Valadan R, et al. Emergence of terbinafine-resistant Trichophyton mentagrophytes in Iran, harboring mutations in the squalene epoxidase (SQLE) gene. Infect Drug Resist. 2020;13(13):845\u201350. https:\/\/doi.org\/10.2147\/IDR.S246025.PMID:32214830;PMCID:PMC7078656.","journal-title":"Infect Drug Resist."},{"issue":"4","key":"738_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/jof6040207.PMID:33027904;PMCID:PMC7712673","volume":"6","author":"P Nenoff","year":"2020","unstructured":"Nenoff P, Verma SB, Ebert A, S\u00fc\u00df A, Fischer E, Auerswald E, et al. Spread of terbinafine-resistant Trichophyton mentagrophytes type VIII (India) in Germany\u2014\u201cthe tip of the iceberg?\u201d J Fungi (Basel). 2020;6(4):207. https:\/\/doi.org\/10.3390\/jof6040207.PMID:33027904;PMCID:PMC7712673.","journal-title":"J Fungi (Basel)."},{"issue":"9","key":"738_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/14787210.2024.2390629","volume":"22","author":"AK Gupta","year":"2024","unstructured":"Gupta AK, Wang T, Mann A, Polla Ravi S, Talukder M, Lincoln SA, et al. Antifungal resistance in dermatophytes\u2014review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae infections. Expert Rev Anti-Infect Ther. 2024;22(9):739\u201351. https:\/\/doi.org\/10.1080\/14787210.2024.2390629. (Epub 2024 Aug 18).","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"1 Part 1","key":"738_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0190-9622(00)90013-6","volume":"42","author":"H C\u00e1ceres-R\u00edos","year":"2000","unstructured":"C\u00e1ceres-R\u00edos H, Rueda M, Ballona R, Bustamante B. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. J Am Acad Dermatol. 2000;42(1 Part 1):80\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"738_CR36","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jaad.2005.07.028","volume":"53","author":"KW Foster","year":"2005","unstructured":"Foster KW, Friedlander SF, Panzer H, Ghannoum MA, Elewski BE. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. J Am Acad Dermatol. 2005;53(5):798\u2013809. https:\/\/doi.org\/10.1016\/j.jaad.2005.07.028.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"738_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-2133.1996.tb03613.x","volume":"135","author":"TS Haroon","year":"1996","unstructured":"Haroon TS, Hussain I, Aman S, Jahangir M, Kazmi AH, Sami AR, et al. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. Br J Dermatol. 1996;135(1):86\u20138.","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"738_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/s0190-9622(97)80140-5","volume":"37","author":"P Kullavanijaya","year":"1997","unstructured":"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 1997;37(2 Pt 1):272\u20133. https:\/\/doi.org\/10.1016\/s0190-9622(97)80140-5.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"738_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2230.2004.01493.x","volume":"29","author":"R Ungpakorn","year":"2004","unstructured":"Ungpakorn R, Ayutyanont T, Reangchainam S, Supanya S. Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine. Clin Exp Dermatol. 2004;29(3):300\u20133. https:\/\/doi.org\/10.1111\/j.1365-2230.2004.01493.x.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"738_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1473-2165.2002.00427.x","volume":"16","author":"H Silm","year":"2002","unstructured":"Silm H, Karelson M. Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis. J Eur Acad Dermatol Venereol. 2002;16(3):228\u201330. https:\/\/doi.org\/10.1046\/j.1473-2165.2002.00427.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"738_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1525-1470.2001.01953.x","volume":"18","author":"E Koumantaki","year":"2001","unstructured":"Koumantaki E, Kakourou T, Rallis E, Riga P, Georgalla S. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol. 2001;18(4):339\u201342. https:\/\/doi.org\/10.1046\/j.1525-1470.2001.01953.x.","journal-title":"Pediatr Dermatol"},{"issue":"9-10","key":"738_CR42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1439-0507.2004.01024.x","volume":"47","author":"N Aste","year":"2004","unstructured":"Aste N, Pau M. Tinea capitis caused by Microsporum canis treated with terbinafine. Mycoses. 2004;47(9\u201310):428\u201330. https:\/\/doi.org\/10.1111\/j.1439-0507.2004.01024.x.","journal-title":"Mycoses"},{"issue":"1","key":"738_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1525-1470.1997.tb00427.x","volume":"14","author":"V Dragos","year":"1997","unstructured":"Dragos V, Lunder M. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children. Pediatr Dermatol. 1997;14(1):46\u20138. https:\/\/doi.org\/10.1111\/j.1525-1470.1997.tb00427.x.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"738_CR44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1046\/j.1365-2133.1999.02713.x","volume":"140","author":"H Hamm","year":"1999","unstructured":"Hamm H, Schwinn A, Br\u00e4utigam M, Weidinger G. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. Br J Dermatol. 1999;140(3):480\u20132. https:\/\/doi.org\/10.1046\/j.1365-2133.1999.02713.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"738_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/s0190-9622(99)70407-x","volume":"41","author":"B Krafchik","year":"1999","unstructured":"Krafchik B, Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. J Am Acad Dermatol. 1999;41(1):60\u20133. https:\/\/doi.org\/10.1016\/s0190-9622(99)70407-x.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"738_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1046\/j.1525-1470.1998.1998015056.x","volume":"15","author":"AK Gupta","year":"1998","unstructured":"Gupta AK, Adam P. Terbinafine pulse therapy is effective in tinea capitis. Pediatr Dermatol. 1998;15(1):56\u20138. https:\/\/doi.org\/10.1046\/j.1525-1470.1998.1998015056.x.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"738_CR47","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1046\/j.1365-2133.2002.04744.x","volume":"146","author":"J Lipozencic","year":"2002","unstructured":"Lipozencic J, Skerlev M, Orofino-Costa R, Zaitz VC, Horvath A, Chouela E, et al. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol. 2002;146(5):816\u201323. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04744.x.","journal-title":"Br J Dermatol"},{"issue":"10","key":"738_CR48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/myc.12970","volume":"62","author":"J Bar","year":"2019","unstructured":"Bar J, Samuelov L, Sprecher E, Mashiah J. Griseofulvin vs terbinafine for paediatric tinea capitis: when and for how long. Mycoses. 2019;62(10):949\u201353. https:\/\/doi.org\/10.1111\/myc.12970. (Epub 2019 Aug 18).","journal-title":"Mycoses"},{"issue":"2 Pt 1","key":"738_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/s0190-9622(97)80141-7","volume":"37","author":"BA Solomon","year":"1997","unstructured":"Solomon BA, Collins R, Sharma R, Silverberg N, Jain AR, Sedgh J, et al. Fluconazole for the treatment of tinea capitis in children. J Am Acad Dermatol. 1997;37(2 Pt 1):274\u20135. https:\/\/doi.org\/10.1016\/s0190-9622(97)80141-7.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"738_CR50","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1046\/j.1365-2133.2000.03479.x","volume":"142","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Dlova N, Taborda P, Morar N, Taborda V, Lynde CW, et al. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. Br J Dermatol. 2000;142(5):965\u20138. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03479.x.","journal-title":"Br J Dermatol"},{"issue":"10","key":"738_CR51","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1468-3083.2009.03271.x","volume":"23","author":"B Binder","year":"2009","unstructured":"Binder B, Richtig E, Weger W, Ginter-Hanselmayer G. Tinea capitis in early infancy treated with itraconazole: a pilot study. J Eur Acad Dermatol Venereol. 2009;23(10):1161\u20133. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03271.x. (Epub 2009 Apr 23).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"738_CR52","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1046\/j.1365-2133.1998.02465.x","volume":"139","author":"M Jahangir","year":"1998","unstructured":"Jahangir M, Hussain I, Ul Hasan M, Haroon TS. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis. Br J Dermatol. 1998;139(4):672\u20134. https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02465.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"738_CR53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.0736-8046.2004.21419.x","volume":"21","author":"G Ginter-Hanselmayer","year":"2004","unstructured":"Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr Dermatol. 2004;21(4):499\u2013502. https:\/\/doi.org\/10.1111\/j.0736-8046.2004.21419.x.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"738_CR54","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1046\/j.1365-2133.2000.03835.x","volume":"143","author":"M M\u00f6hrenschlager","year":"2000","unstructured":"M\u00f6hrenschlager M, Schnopp C, Fesq H, Strom K, Beham A, Mempel M, et al. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole. Br J Dermatol. 2000;143(5):1011\u20135. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03835.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"738_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/jof9030366","volume":"9","author":"J Dascalu","year":"2023","unstructured":"Dascalu J, Zaaroura H, Renert-Yuval Y, Khamaysi Z, Avitan-Hersh E, Friedland R. Pediatric tinea capitis: a retrospective cohort study from 2010 to 2021. J Fungi (Basel). 2023;9(3):366. https:\/\/doi.org\/10.3390\/jof9030366.","journal-title":"J Fungi (Basel)"},{"issue":"10","key":"738_CR56","doi-asserted-by":"publisher","first-page":"706","DOI":"10.31128\/AJGP-05-19-4930","volume":"48","author":"T Kovitwanichkanont","year":"2019","unstructured":"Kovitwanichkanont T, Chong AH. Superficial fungal infections. Aust J Gen Pract. 2019;48(10):706\u201311. https:\/\/doi.org\/10.31128\/AJGP-05-19-4930.","journal-title":"Aust J Gen Pract"},{"issue":"6","key":"738_CR57","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1592\/phco.22.9.697.34072","volume":"22","author":"BD Bradbury","year":"2002","unstructured":"Bradbury BD, Jick SS. Itraconazole and fluconazole and certain rare, serious adverse events. Pharmacotherapy. 2002;22(6):697\u2013700. https:\/\/doi.org\/10.1592\/phco.22.9.697.34072.","journal-title":"Pharmacotherapy"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00738-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00738-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00738-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:13:07Z","timestamp":1773673987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-026-00738-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00738-5","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All data generated or analyzed during this study are included in this published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Chester Tyson conceived and designed this narrative review, performed the literature search and synthesis, and prepared the manuscript draft. Dean Morrell, Diana McShane, Elizabeth Nieman, and Caitlin Haydek reviewed the manuscript and provided critical feedback. All authors approved of the final version.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}